A study of nearly 65,000 people suggests that devices coated with a drug called paclitaxel that are used for widening blocked arteries in legs and feet are safe and not linked to an increase in deaths ...

Drug-eluting stents are highly effective in reducing the rate of in-stent restenosis. It is not known whether there are differences in the effectiveness of currently approved drug-eluting stents in ...

The United States Food and Drug Administration today, in a letter to healthcare providers, reversed its restrictions on the use of paclitaxel-based therapies in peripheral vascular interventions (PVIs ...

In phase 3 trial results presented at the San Antonio Breast Cancer Symposium in San Antonio, Texas, oral paclitaxel with encequidar, the first orally administered paclitaxel, was shown to exhibit ...

Low-dose weekly paclitaxel is as effective as and has fewer side effects than the standard biweekly schedule for patients with early-stage breast cancer, according to the results of a phase III study ...

SAN ANTONIO — In a first of its kind result, an investigational oral form of paclitaxel yielded a higher overall response rate than the IV form of the chemotherapy drug among women with metastatic ...

Two major side-effects of paclitaxel therapy are frequent hypersensitivity reactions and neuropathy. Standard paclitaxel contains Cremophor EL as a solvent, thus requiring premedication with high ...

SAN FRANCISCO, CA—A patient-level, pooled meta-analysis of trials looking at paclitaxel-coated versus uncoated devices in peripheral vascular interventions (PVIs), with median follow-up out to 4.9 ...

Researchers at the University of Arizona R. Ken Coit College of Pharmacy have developed a new strategy that helps the immune system recognize and attack lung cancer tumors more effectively. By ...

Recently at ASCO 2019, ETNA investigators reported that the secondary endpoint of 5-year EFS was not statistically significantly different between neoadjuvant nab-paclitaxel compared to s-paclitaxel.